Genmab Tech Stack
Antibody drug developer advancing late-stage oncology pipeline
Genmab is a Copenhagen-based biotech company developing antibody-based therapeutics for cancer and serious diseases, with a late-stage clinical pipeline and commercial product launches underway. The tech stack reveals a data-intensive organization: Databricks, Delta Lake, Apache Airflow, and dbt form a modern analytics foundation, while Veeva dominates regulatory and quality workflows—standard for biotech at scale. Hiring is accelerating across healthcare, research, and data functions, with notable leadership gaps in clinical trial delivery and medical affairs, suggesting active portfolio expansion and a push to compress time-to-market in a competitive space.
Tech Stack 54 technologies
What Genmab Is Building
◆Challenges
- Ensuring gxp compliance
- Risk mitigation
- Improving data management processes
- Launching new hematology product
- Improving efficiencies in clinical development
- Minimizing risk and cost
- Inspection readiness
- Time-to-market
- Compliance with us gaap and ifrs
- Timely delivery of clinical trial supplies
▲Active Projects
- Product launches
- Territory business plan development
- Market trend analysis for epkinly uptake
- Epkinly engagement strategy
- Clinical trial delivery
- Contracting and sourcing trial strategies
- Global medical affairs strategy for hnscc
- Weaving ml/ai into drug discovery
- Investigator sponsored trials
- Master clinical trial (mctas) implementation
Hiring Activity
Department
Seniority
Notable leadership hires: Development Team Lead, Business Director, Global Trial Lead, Trial Lead, Medical Lead
